Abstract
Technological advances in next-generation DNA sequencing now allow fast and cost-effective sequencing of the “exome,”defined as all the exons in the genome. Such is the rapidity and accessibility of this technique that whole exome sequencing (WES) is becoming a first-line diagnostic tool for the investigation of many diseases, including cancers, metabolic disorders, and childhood neurodevelopmental disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
